PDCD1 and posterior cortical atrophy: Consistent with these results, we recently found that genetic deletion or small molecule inhibition of the IRE1α-XBP1s signaling led to an increased response to anti-PD-1 ICI therapy in various syngeneic PCa mouse models [82].